P/B
7,7
Absci
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
$1.9B
Market Cap • 10/2/2026
2011
(15 years)
Founded
2021
(5 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
1217
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
1,4
EPS
—
Market Cap
Market Cap
1,9B
EV
1,7B
EV/Revenue
1090,6
EV/EBITDA
-14,8
EV/EBIT
-13,5
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-9,3%
Total Yield
-9,3%
Payout
0%
Retained Earnings
-687,6M
Profitability
Gross Margin
100%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
5540,5%
Capex/Revenue
57%
Capex/D&A
8%
Capex/OCF
-0,8%
SBC/OCF
—
% PPE
7,1%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
-22,1%
CAGR Op. Income 5Y
28,6%
CAGR Net Income 5Y
14,8%
CAGR EPS 5Y
-28,5%
CAGR OCF 5Y
32%
Leverage
N.D./EBITDA
1,7
Debt/Equity
0%
Current Ratio
10,6
Quick Ratio
10,3
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!